{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:42:46Z","timestamp":1755801766388,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"crossref","award":["26350","26350","26350","26350","26350","26350"],"award-info":[{"award-number":["26350","26350","26350","26350","26350","26350"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13100-5","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T19:12:36Z","timestamp":1755717156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1488-268X","authenticated-orcid":false,"given":"Ashkan","family":"Shabannezhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-5964","authenticated-orcid":false,"given":"Nasrin","family":"Alizadghandforoush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0070-6620","authenticated-orcid":false,"given":"Majid","family":"Safa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7739-2757","authenticated-orcid":false,"given":"Shahrbano","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1263-2913","authenticated-orcid":false,"given":"Bahram","family":"Chahardouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8759-6120","authenticated-orcid":false,"given":"Ali","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"11","key":"13100_CR1","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/ajh.27443","volume":"99","author":"E Jabbour","year":"2024","unstructured":"Jabbour, E. & Kantarjian, H. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring. Am. J. Hematol. 99(11), 2191\u20132212. https:\/\/doi.org\/10.1002\/ajh.27443 (2024).","journal-title":"Am. J. Hematol."},{"key":"13100_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580759","volume":"10","author":"Q Lin","year":"2020","unstructured":"Lin, Q. et al. Global, regional, and national burden of chronic myeloid leukemia, 1990\u20132017: A systematic analysis for the global burden of disease study 2017. Front. Oncol. 10, 580759. https:\/\/doi.org\/10.3389\/fonc.2020.580759 (2020).","journal-title":"Front. Oncol."},{"issue":"Suppl 2","key":"13100_CR3","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1007\/s00277-015-2314-2","volume":"94","author":"M Hoglund","year":"2015","unstructured":"Hoglund, M., Sandin, F. & Simonsson, B. Epidemiology of chronic myeloid leukaemia: An update. Ann. Hematol. 94(Suppl 2), S241\u2013S247. https:\/\/doi.org\/10.1007\/s00277-015-2314-2 (2015).","journal-title":"Ann. Hematol."},{"issue":"5","key":"13100_CR4","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.canep.2022.102175","volume":"35","author":"C-S Chang","year":"2011","unstructured":"Chang, C.-S. et al. Estimation of CML incidence: Disagreement between national cancer registry and health claims data system in Taiwan. Leuk. Res. 35(5), e53\u2013e54. https:\/\/doi.org\/10.1016\/j.canep.2022.102175 (2011).","journal-title":"Leuk. Res."},{"issue":"7","key":"13100_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3109\/10428194.2012.745525","volume":"54","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk Lymphoma 54(7), 1411\u20131417. https:\/\/doi.org\/10.3109\/10428194.2012.745525 (2013).","journal-title":"Leuk Lymphoma"},{"key":"13100_CR6","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.12688\/f1000research.74570.2","volume":"10","author":"M Al Hamad","year":"2022","unstructured":"Al Hamad, M. Contribution of BCR-ABL molecular variants and leukemic stem cells in response and resistance to tyrosine kinase inhibitors: A review. F1000Research 10, 1288. https:\/\/doi.org\/10.12688\/f1000research.74570.2 (2022).","journal-title":"F1000Research"},{"issue":"2","key":"13100_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5045\/br.2022.2021173","volume":"57","author":"MA Samad","year":"2022","unstructured":"Samad, M. A., Mahboob, E. & Mansoor, H. Chronic myeloid leukemia: a type of MPN. Blood Res. 57(2), 95\u2013100. https:\/\/doi.org\/10.5045\/br.2022.2021173 (2022).","journal-title":"Blood Res."},{"issue":"4","key":"13100_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/cancers13040798","volume":"13","author":"M Suttorp","year":"2021","unstructured":"Suttorp, M. et al. Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia. Cancers (Basel) 13(4), 798. https:\/\/doi.org\/10.3390\/cancers13040798 (2021).","journal-title":"Cancers (Basel)"},{"key":"13100_CR9","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1007\/s11033-014-3472-3","volume":"41","author":"A Amini","year":"2014","unstructured":"Amini, A. et al. Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia. Mol. Biol. Rep. 41, 5557\u20135561. https:\/\/doi.org\/10.1007\/s11033-014-3472-3 (2014).","journal-title":"Mol. Biol. Rep."},{"issue":"5405","key":"13100_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley, J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243(5405), 290\u2013293. https:\/\/doi.org\/10.1038\/243290a0 (1973).","journal-title":"Nature"},{"issue":"6","key":"13100_CR11","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1182\/blood.V82.6.1838.1838","volume":"82","author":"RA Mandanas","year":"1993","unstructured":"Mandanas, R. A. et al. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells. Blood 82(6), 1838\u20131847. https:\/\/doi.org\/10.1182\/blood.V82.6.1838.1838 (1993).","journal-title":"Blood"},{"issue":"11","key":"13100_CR12","first-page":"1111","volume":"22","author":"K Okuda","year":"1994","unstructured":"Okuda, K. et al. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. Exp. Hematol. 22(11), 1111\u20131117 (1994).","journal-title":"Exp. Hematol."},{"issue":"25","key":"13100_CR13","doi-asserted-by":"publisher","first-page":"11746","DOI":"10.1073\/pnas.92.25.11746","volume":"92","author":"AB Raitano","year":"1995","unstructured":"Raitano, A. B. et al. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA 92(25), 11746\u201311750. https:\/\/doi.org\/10.1073\/pnas.92.25.11746 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"13100_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","volume":"70","author":"CL Sawyers","year":"1992","unstructured":"Sawyers, C. L., Callahan, W. & Witte, O. N. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70(6), 901\u2013910. https:\/\/doi.org\/10.1016\/0092-8674(92)90241-4 (1992).","journal-title":"Cell"},{"issue":"3","key":"13100_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1084\/jem.183.3.811","volume":"183","author":"N Carlesso","year":"1996","unstructured":"Carlesso, N., Frank, D. A. & Griffin, J. D. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl. J. Exp. Med. 183(3), 811\u2013820. https:\/\/doi.org\/10.1084\/jem.183.3.811 (1996).","journal-title":"J. Exp. Med."},{"issue":"2","key":"13100_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0092-8674(00)80919-8","volume":"92","author":"N Hacohen","year":"1998","unstructured":"Hacohen, N. et al. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92(2), 253\u2013263. https:\/\/doi.org\/10.1016\/S0092-8674(00)80919-8 (1998).","journal-title":"Cell"},{"issue":"11","key":"13100_CR17","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1242\/dev.126.11.2515","volume":"126","author":"S Kramer","year":"1999","unstructured":"Kramer, S. et al. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126(11), 2515\u20132525. https:\/\/doi.org\/10.1242\/dev.126.11.2515 (1999).","journal-title":"Development"},{"issue":"10","key":"13100_CR18","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1046\/j.1432-1033.2002.02921.x","volume":"269","author":"OC Leeksma","year":"2002","unstructured":"Leeksma, O. C. et al. Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1. Eur. J. Biochem. 269(10), 2546\u20132556. https:\/\/doi.org\/10.1046\/j.1432-1033.2002.02921.x (2002).","journal-title":"Eur. J. Biochem."},{"key":"13100_CR19","doi-asserted-by":"publisher","first-page":"1376873","DOI":"10.3389\/fonc.2024.1376873","volume":"14","author":"H Pan","year":"2024","unstructured":"Pan, H., Xu, R. & Zhang, Y. Role of SPRY4 in health and disease. Front. Oncol. 14, 1376873. https:\/\/doi.org\/10.3389\/fonc.2024.1376873 (2024).","journal-title":"Front. Oncol."},{"issue":"1","key":"13100_CR20","doi-asserted-by":"publisher","first-page":"L52","DOI":"10.1152\/ajplung.00430.2003","volume":"287","author":"W Ding","year":"2004","unstructured":"Ding, W. et al. Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis. Am. J. Physiol. Lung Cell Mol. Physiol. 287(1), L52\u2013L59. https:\/\/doi.org\/10.1152\/ajplung.00430.2003 (2004).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2\u20133","key":"13100_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10555-014-9497-1","volume":"33","author":"S Masoumi-Moghaddam","year":"2014","unstructured":"Masoumi-Moghaddam, S., Amini, A. & Morris, D. L. The developing story of Sprouty and cancer. Cancer Metastasis. Rev. 33(2\u20133), 695\u2013720. https:\/\/doi.org\/10.1007\/s10555-014-9497-1 (2014).","journal-title":"Cancer Metastasis. Rev."},{"issue":"1","key":"13100_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tcb.2005.11.004","volume":"16","author":"JM Mason","year":"2006","unstructured":"Mason, J. M. et al. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16(1), 45\u201354. https:\/\/doi.org\/10.1016\/j.tcb.2005.11.004 (2006).","journal-title":"Trends Cell Biol."},{"issue":"4","key":"13100_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bbrc.2006.11.107","volume":"352","author":"K Taniguchi","year":"2007","unstructured":"Taniguchi, K. et al. Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. Biochem. Biophys. Res. Commun. 352(4), 896\u2013902. https:\/\/doi.org\/10.1016\/j.bbrc.2006.11.107 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"13100_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbrc.2014.04.012","volume":"447","author":"T Fukaya","year":"2014","unstructured":"Fukaya, T. et al. Loss of Sprouty4 in T cells ameliorates experimental autoimmune encephalomyelitis in mice by negatively regulating IL-1beta receptor expression. Biochem. Biophys. Res. Commun. 447(3), 471\u2013478. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.012 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"13100_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2015.11.050","volume":"612","author":"L Klimaschewski","year":"2016","unstructured":"Klimaschewski, L., Sueiro, B. P. & Millan, L. M. siRNA mediated down-regulation of Sprouty2\/4 diminishes ischemic brain injury. Neurosci. Lett. 612, 48\u201351. https:\/\/doi.org\/10.1016\/j.neulet.2015.11.050 (2016).","journal-title":"Neurosci. Lett."},{"issue":"8","key":"13100_CR26","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.18632\/aging.202859","volume":"13","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2. Aging (Albany NY) 13(8), 11665\u201311677. https:\/\/doi.org\/10.18632\/aging.202859 (2021).","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"13100_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13234","volume":"83","author":"S Qin","year":"2020","unstructured":"Qin, S. et al. SPRY4 regulates trophoblast proliferation and apoptosis via regulating IFN-gamma-induced STAT1 expression and activation in recurrent miscarriage. Am. J. Reprod. Immunol. 83(6), e13234. https:\/\/doi.org\/10.1111\/aji.13234 (2020).","journal-title":"Am. J. Reprod. Immunol."},{"key":"13100_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroscience.2014.12.020","volume":"287","author":"Y Goldshmit","year":"2015","unstructured":"Goldshmit, Y. et al. Decreased anti-regenerative effects after spinal cord injury in spry4-\/- mice. Neuroscience 287, 104\u2013112. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.020 (2015).","journal-title":"Neuroscience"},{"issue":"5","key":"13100_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005467","volume":"4","author":"K Taniguchi","year":"2009","unstructured":"Taniguchi, K. et al. Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. PLoS ONE 4(5), e5467. https:\/\/doi.org\/10.1371\/journal.pone.0005467 (2009).","journal-title":"PLoS ONE"},{"issue":"29","key":"13100_CR30","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.3748\/wjg.v26.i29.4240","volume":"26","author":"ZS Niu","year":"2020","unstructured":"Niu, Z. S. et al. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World J. Gastroenterol. 26(29), 4240\u20134260. https:\/\/doi.org\/10.3748\/wjg.v26.i29.4240 (2020).","journal-title":"World J. Gastroenterol."},{"key":"13100_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-5-2-90","volume":"5","author":"MW Wright","year":"2011","unstructured":"Wright, M. W. & Bruford, E. A. Naming\u2019junk\u2019: Human non-protein coding RNA (ncRNA) gene nomenclature. Hum. Genom. 5, 1\u20139. https:\/\/doi.org\/10.1186\/1479-7364-5-2-90 (2011).","journal-title":"Hum. Genom."},{"issue":"11","key":"13100_CR32","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41388-018-0534-3","volume":"38","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP. Oncogene 38(11), 1892\u20131904. https:\/\/doi.org\/10.1038\/s41388-018-0534-3 (2019).","journal-title":"Oncogene"},{"key":"13100_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112896","volume":"149","author":"M Zou","year":"2022","unstructured":"Zou, M. et al. Dysregulation of miR-411 in cancer: Causative factor for pathogenesis, diagnosis and prognosis. Biomed. Pharmacother 149, 112896. https:\/\/doi.org\/10.1016\/j.biopha.2022.112896 (2022).","journal-title":"Biomed. Pharmacother"},{"issue":"D1","key":"13100_CR34","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara, A., Birgaoanu, M. & Griffiths-Jones, S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 47(D1), D155\u2013D162. https:\/\/doi.org\/10.1093\/nar\/gky1141 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"13100_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12957-021-02164-y","volume":"19","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt\/beta-catenin pathway. World J. Surg. Oncol. 19(1), 51. https:\/\/doi.org\/10.1186\/s12957-021-02164-y (2021).","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"13100_CR36","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3892\/etm.2020.8899","volume":"20","author":"F He","year":"2020","unstructured":"He, F. et al. hsa-microRNA-411-5p regulates proliferation, migration and invasion by targeting the hyaluronan mediated motility receptor in ovarian cancer. Exp. Ther. Med. 20(3), 1899\u20131906. https:\/\/doi.org\/10.3892\/etm.2020.8899 (2020).","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"13100_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/mmr.2019.10826","volume":"21","author":"W Wei","year":"2020","unstructured":"Wei, W. & Liu, C. Prognostic and predictive roles of microRNA-411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer. Mol. Med. Rep. 21(1), 267\u2013281. https:\/\/doi.org\/10.3892\/mmr.2019.10826 (2020).","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"13100_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbrc.2016.06.006","volume":"476","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochem. Biophys. Res. Commun. 476(4), 607\u2013613. https:\/\/doi.org\/10.1016\/j.bbrc.2016.06.006 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"13100_CR39","doi-asserted-by":"publisher","first-page":"e1859","DOI":"10.1038\/cddis.2015.225","volume":"6","author":"M Sun","year":"2015","unstructured":"Sun, M. et al. Autoregulatory loop between TGF-\u03b21\/miR-411-5p\/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation. Cell Death Dis. 6(8), e1859\u2013e1859. https:\/\/doi.org\/10.1038\/cddis.2015.225 (2015).","journal-title":"Cell Death Dis."},{"key":"13100_CR40","doi-asserted-by":"publisher","first-page":"1376873","DOI":"10.3389\/fonc.2024.1376873","volume":"14","author":"H Pan","year":"2024","unstructured":"Pan, H. & Zhang, Y. Role of SPRY4 in health and disease. Front. Oncol. 14, 1376873. https:\/\/doi.org\/10.3389\/fonc.2024.1376873 (2024).","journal-title":"Front. Oncol."},{"issue":"19","key":"13100_CR41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41388-023-02673-y","volume":"42","author":"G Romano","year":"2023","unstructured":"Romano, G. et al. A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells. Oncogene 42(19), 1597\u20131606. https:\/\/doi.org\/10.1038\/s41388-023-02673-y (2023).","journal-title":"Oncogene"},{"issue":"1","key":"13100_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/pharmaceutics14010215","volume":"14","author":"GP Amarante-Mendes","year":"2022","unstructured":"Amarante-Mendes, G. P. et al. BCR-ABL1 tyrosine kinase complex signaling transduction: Challenges to overcome resistance in chronic myeloid leukemia. Pharmaceutics 14(1), 215. https:\/\/doi.org\/10.3390\/pharmaceutics14010215 (2022).","journal-title":"Pharmaceutics"},{"issue":"8","key":"13100_CR43","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama, A. & Cortes, J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113(8), 1619\u20131630. https:\/\/doi.org\/10.1182\/blood-2008-03-144790 (2009).","journal-title":"Blood"},{"key":"13100_CR44","doi-asserted-by":"publisher","unstructured":"Tari, A. M. & Lopez-Berestein, G. GRB2: A pivotal protein in signal transduction. In Seminars in oncology. (Elsevier, 2001). https:\/\/doi.org\/10.1016\/S0093-7754(01)90291-X","DOI":"10.1016\/S0093-7754(01)90291-X"},{"key":"13100_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.biopha.2015.01.001","volume":"70","author":"K Xia","year":"2015","unstructured":"Xia, K. et al. miR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells. Biomed. Pharmacother. 70, 158\u2013163. https:\/\/doi.org\/10.1016\/j.biopha.2015.01.001 (2015).","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"13100_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/CBM-190812","volume":"29","author":"WX Zhao","year":"2020","unstructured":"Zhao, W. X. et al. Up-regulation of circ_0000353 impedes the proliferation and metastasis of non-small cell lung cancer cells via adsorbing miR-411-5p and increasing forkhead box O1. Cancer Biomark 29(1), 25\u201337. https:\/\/doi.org\/10.3233\/CBM-190812 (2020).","journal-title":"Cancer Biomark"},{"issue":"12","key":"13100_CR47","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1007\/s11356-018-1331-9","volume":"25","author":"N Xu","year":"2018","unstructured":"Xu, N. et al. MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression. Environ. Sci. Pollut. Res. Int. 25(12), 12064\u201312071. https:\/\/doi.org\/10.1007\/s11356-018-1331-9 (2018).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"5","key":"13100_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0092-8674(00)80576-0","volume":"96","author":"T Casci","year":"1999","unstructured":"Casci, T., Vinos, J. & Freeman, M. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96(5), 655\u2013665. https:\/\/doi.org\/10.1016\/S0092-8674(00)80576-0 (1999).","journal-title":"Cell"},{"key":"13100_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ebiom.2019.11.021","volume":"50","author":"B Qiu","year":"2019","unstructured":"Qiu, B. et al. Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle. EBioMedicine 50, 166\u2013177. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.021 (2019).","journal-title":"EBioMedicine"},{"issue":"6","key":"13100_CR50","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1159\/000453195","volume":"40","author":"X Zhou","year":"2016","unstructured":"Zhou, X. et al. Lower expression of SPRY4 predicts a poor prognosis and regulates cell proliferation in colorectal cancer. Cell Physiol. Biochem. 40(6), 1433\u20131442. https:\/\/doi.org\/10.1159\/000453195 (2016).","journal-title":"Cell Physiol. Biochem."},{"key":"13100_CR51","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00277-015-2445-5","volume":"94","author":"O Geiger","year":"2015","unstructured":"Geiger, O. et al. Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia. Ann. Hematol. 94, 1923\u20131924. https:\/\/doi.org\/10.1007\/s00277-015-2445-5 (2015).","journal-title":"Ann. Hematol."},{"issue":"1","key":"13100_CR52","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41598-018-20846-8","volume":"8","author":"MK Das","year":"2018","unstructured":"Das, M. K. et al. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours. Sci. Rep. 8(1), 2462. https:\/\/doi.org\/10.1038\/s41598-018-20846-8 (2018).","journal-title":"Sci. Rep."},{"key":"13100_CR53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.omtn.2020.09.038","volume":"22","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. LINC00675 suppresses cell proliferation and migration via downregulating the H3K4me2 level at the SPRY4 promoter in gastric cancer. Molecular Therapy-Nucleic Acids 22, 766\u2013778. https:\/\/doi.org\/10.1016\/j.omtn.2020.09.038 (2020).","journal-title":"Molecular Therapy-Nucleic Acids"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13100-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13100-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13100-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T19:12:38Z","timestamp":1755717158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13100-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13100"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13100-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committee of Iran University of Medical Sciences (agreement number IR.IUMS.REC.1402.196).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants for publication of the details of their medical cases before the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"30647"}}